Manhattan Scientifics Inc. ( OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study.
Manhattan Scientifics Inc. ( OTC: QB ), initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. ( IBX.AX ).
Manhattan Scientifics Inc. ( OTCQB: MHTX ) invested $30 million and a 10-year effort to commercialize the Imagion Biosystems ( IBX: AX ) super early, non- invasive, non-radioactive Cancer diagnostic, now...
Manhattan Scientifics Inc. ( OTCQB: MHTX ) a company that acquires, develops and commercializes life-enhancing technologies is pleased to announce year-end business updates on its two nano technologies...
Manhattan Scientifics Inc. (MHTX: OTCQB) provides a 45-minute interview with Imagion Biosystems Chairman/CEO Bob Proulx describing the very-early-cancer-diagnostic development that MHTX incubated and helped...
Manhattan Scientifics, Inc. ( OTCQB:MHTX ) owns 50+ Million shares of its former wholly-owned subsidiary cancer diagnostic company Imagion Biosystems Ltd. ( AX:IBX ). Volume trading yesterday exceeded...